Every material Form 8-K Turning Point Brands, Inc. has filed with the SEC since May 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Turning Point Brands reported third-quarter 2026 results, with net sales up 27.0% to $151.1 million, driven by growth in its Modern Oral products. Net income attributable to the company fell 81.4% to $3.9 million, and diluted EPS was $0.19 versus $1.13 a year earlier, as sales and marketing spending increased. The company reaffirmed its full-year 2026 guidance, which it had last updated on September 21, 2026.
Net sales rose 27.0% to $151.1 million; Modern Oral net sales rose 102.9% to $74.4 million.
Net income attributable to Turning Point Brands fell 81.4% to $3.9 million; diluted EPS was $0.19 versus $1.13.
Adjusted EBITDA fell 41.3% to $18.4 million, including increased sales and marketing investments.
Full-year 2026 guidance reaffirmed: Modern Oral net sales of $260-$270 million and Adjusted EBITDA of $70-$80 million.
Turning Point Brands CEO Graham Purdy resigned for personal reasons and will also leave the board effective September 30, 2026. The board named Executive Chairman David E. Glazek as CEO effective October 1, 2026. The company reaffirmed its 2026 Modern Oral sales guidance but lowered the top of its EBITDA guidance range, which matters to shareholders because it signals a leadership transition alongside a narrower profit outlook.
Graham Purdy steps down as President and CEO and as a director effective September 30, 2026; the company says the departure is not related to any disagreement.
David E. Glazek, Executive Chairman since 2023 and a director since 2012, becomes CEO effective October 1, 2026.
2026 Modern Oral gross sales guidance of $330 million to $350 million and net sales guidance of $260 million to $270 million were reaffirmed.
Full-year 2026 EBITDA guidance was tightened to $70 million to $80 million from $70 million to $90 million.
Turning Point Brands reported second-quarter 2026 net sales of $142.9 million, up 22.6% from a year earlier, but net income attributable to the company fell 75.2% to $3.6 million, and adjusted EBITDA fell 50.0% to $15.2 million. The company raised its full-year 2026 Modern Oral sales guidance, while its SG&A expenses rose 91.1% to $76.9 million.
Q2 2026 net sales rose 22.6% to $142.9 million; Modern Oral net sales rose 128% to $68.4 million.
Diluted EPS was $0.18 versus $0.79 a year earlier; adjusted diluted EPS was $0.23 versus $0.98.
Full-year 2026 Modern Oral net sales guidance raised to $260-$270 million from $210-$225 million.
Gross profit rose 40.6% to $93.7 million, helped by a tariff refund; excluding out-of-period COGS tied to the refund, gross profit was $81.5 million.
Turning Point Brands reported first-quarter 2026 net sales up 16.8% to $124.3 million, but net income attributable to the company fell 19.0% to $11.7 million and diluted EPS dropped to $0.60 from $0.79. The company raised its full-year 2026 Modern Oral sales guidance and introduced full-year Adjusted EBITDA guidance of $70 million to $90 million, so shareholders get higher sales expectations alongside lower first-quarter profit.
Q1 2026 net sales rose 16.8% to $124.3 million; Stoker's rose 48.1% while Zig-Zag fell 22.4%
Net income attributable to the company was $11.7 million, down 19.0%; Adjusted EBITDA fell 6.5% to $25.9 million
FY2026 Modern Oral net sales guidance raised to $210 million-$225 million from $180 million-$190 million
Operating cash flow was negative $22.3 million for the quarter, and cash ended March 31, 2026 at $192.4 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Turning Point Brands, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →